Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis
Titel:
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis
Auteur:
Simonini, Gabriele Taddio, Andrea Cattalini, Marco Caputo, Roberto de Libero, Cinzia Parentin, Fulvio Pagnini, Ilaria Lepore, Loredana Cimaz, Rolando